SCHEMBL3978096

SCHEMBL3978096

NNC(=O)c1occc1-c1cccc(Oc2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 1/20 0.48
GAA P10253 3/20 0.43
HDAC8 Q9BY41 1/20 0.43
GALR3 O60755 1/20 0.42
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 1/20 0.41
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40
AKR1C3 P42330 1/20 0.40
FABP1 P07148 1/20 0.39
MITF O75030 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3976519 0.88 NPC1 (0.44) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL3975306 0.85 SMPD1 (0.49) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL27605323 0.85 MEN1 (0.52) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL3973274 0.84 NR1H4 (0.51) SMN1; SMN2ALDH1A1KDM4EGAAHDAC8
SCHEMBL4285451 0.83 MAPT (0.43) MEN1MAPTKMT2AALDH1A1KDM4E
SCHEMBL3976205 0.82 LTA4H (0.39) MEN1MAPTKMT2ASMN1; SMN2ALDH1A1
SCHEMBL3978209 0.81 CA12 (0.39) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL3978696 0.80 PTGER4 (0.44) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL3977084 0.80 ALDH1A1 (0.52) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL3976016 0.79 MEN1 (0.43) MEN1MAPTKMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 MEN1 1481/4885MAPT 4833/4885KMT2A 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.